Tag Archives: health

ICYMI: Peter Pitts Weighs in on Drug Price Debate

health care, medicine

This week in the Sacramento Bee, Peter J. Pitts, a former U.S. Food and Drug Administration associate commissioner and now president of the Center for Medicine in the Public Interest, wrote an op-ed regarding the ongoing drug pricing debate titled “Rising Drug Prices The Fault Of Insurers, Not Drug Companies.” Pitts lists two essential factors that are often overlooked in this discussion: First, the very real financial pain many Americans feel at the pharmacy counter Read More >

Health  |  Leave a comment  |  Email This Post
Tags: , , ,

High Tech Animals Stuck On the Shelf

piggy

David Warmflash writes for the Genetic Literacy Project about the challenges being faced by innovators using genetically engineered animals to solve some of the world’s most pressing health, environmental and societal problems.  Warmflash is an astrobiologist, physician and science writer: If genetically modified (GM) and genetically edited (GE) plants face an uphill battle in moving from proof-of-concept to the dinner tables of consumers, then GM and GE animals are up against a proverbial Mount Everest. Read More >

Farmer Gene  |  Leave a comment  |  Email This Post
Tags: , , , , , , , , , , , , ,

BIO Principles Put Patients First

Greenwood_Jim_BTN

Patient advocacy organizations play an indispensable role in the biopharmaceutical development process: They help scientists and researchers better understand what it’s like to live with the diseases they’re trying to cure. That’s why BIO and our member companies are deeply committed to meaningful partnerships with patient advocacy organizations as we work to discover new medications to help patients live longer, healthier, more fulfilling lives. Today, there are more than 250 biotechnology health care medications and Read More >

Jim's Corner  |  Leave a comment  |  Email This Post
Tags: , , , , , , , ,

WSJ: A Piece of the Immunotherapy Puzzle Solved

Just two weeks ago, the New York Times published a series of articles deeming immunotherapy as the future for cancer advances and new life-saving treatments – even though it’s not entirely clear why only some patients have success with the treatments. This week, the Wall Street Journal joined the immunotherapy conversation by highlighting two researchers who may have unlocked part of the mystery as to why only some patients benefit from immunotherapy. When Dr. Michael Read More >

Health  |  Leave a comment  |  Email This Post
Tags: , , , , , , , , ,

What We’re Reading at GMO Answers

GMO-Fish-and-Tomato-2015

Each month, GMO Answers compiles a few of our favorite news stories into one post on the GMO Answers website.  This post can cover a wide variety of topics related to agriculture and biotechnology, ranging from global hunger and climate change, to genetically modified insulin and the marketing of foods. This month’s post uses the Zika outbreak in Brazil as a jumping off point, and finishes up with a nice profile of Dr. Calestous Juma Read More >

Farmer Gene  |  Leave a comment  |  Email This Post
Tags: , , , , , , , , , , , , , , , ,